
Revisão sistemática e meta-análise sobre biópsia do tumor renal: precisão, segurança e impacto na tomada de decisões clínicas
NefrologiaResumo original em inglês
O que aconteceu
We performed a systematic review and meta-analysis to evaluate the diagnostic accuracy, safety, and clinical impact of renal tumor biopsy (RTB) in managing renal cell carcinoma.
O que encontraram
MEDLINE, Embase, and Cochrane CENTRAL were systematically searched for studies evaluating diagnostic accuracy, complications, and clinical impact of RTB. Diagnostic performance was synthesized using hierarchical bivariate random-effects models; concordance between biopsy and surgical specimens was assessed using pooled proportions that were estimated using random-effects meta-analysis. Risk of bias was evaluated with QUADAS-2.
Por que isso importa
RTB is safe and high-yield, with excellent sensitivity, high concordance for benign vs malignant and histotype, but only moderate reliability for tumor grade. RTB is therefore an important aid in refining diagnosis in patients with a renal mass and supporting individualized decision-making.
O que ainda não sabemos
Overall, 103 studies were included. The pooled diagnostic yield of RTB was 90%. Summary sensitivity and specificity for malignancy were 99% and 85%, respectively. Concordance between RTB and surgical pathology was high for benign versus malignant (96%) and histological subtype (89%), but moderate for grade (four-tier: 64%; two-tier: 78%). The overall complication rate was low (3%), with negligible (<1%) Clavien-Dindo ≥3 complications and 1% bleeding events (with only two patients requiring embolization). Tumor seeding was reported only in one study with a pooled seeding proportion of 0%. RTB findings was associated with a change in clinical management in 39% of patients and avoidance of active treatment in 28%. Most studies were at high risk of bias, mainly due to patient selection and flow/timing, and were predominantly retrospective.
Resumo publicado sob licença CC BY. A tradução para o português ainda não chegou a este estudo.
O estudo original
Systematic Review and Meta-analysis on Renal Tumor Biopsy: Accuracy, Safety, and Impact on Clinical Decision-making
Georges Mjaess, Michele Nicolazzini, Daniele Amparore, Axel Bex, Riccardo Campi, Francesco Cei, Sabrina L Noyes, Chiara Re, Giuseppe Rosiello, Grant D Stewart et al.
Descritores MeSH
- Clinical Decision-Making
- Carcinoma, Renal Cell
- Kidney Neoplasms
- Reproducibility of Results
- Humans
- Neoplasm Grading
- Predictive Value of Tests
- Risk Factors
- Clinical Relevance
- Biopsy
Veja também
Estudos relacionados
- Accuracy of CT-Based Radiomics Models for Preoperative Grading of Clear Cell Renal Cell Carcinoma: A Systematic Review and Meta-analysis
- A meta-analysis on the safety and accuracy of the HEART pathway for risk stratification in patients with acute chest pain
- A systematic review of the accuracy of prognostic tests and scoring systems for use in the Global Vascular Guidelines' PLAN concept for the treatment of chronic limb threatening ischemia
- The Tissue Systems Pathology Test Outperforms Pathology Review in Risk Stratifying Patients With Low-Grade Dysplasia
- Radiomics and Image-based Artificial Intelligence for Predicting Recurrence and Survival After Surgery in Localized Renal Cell Carcinoma: An APPRAISE-AI Systematic Review and Meta-analysis
- European Association of Urology Guidelines on Renal Cell Carcinoma: The 2025 Update